Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 8Esophageal Squamous Cell Carcinoma 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Rectal Neoplasms 2Intestinal Neoplasms 2Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Esophageal Neoplasms 2Digestive System Neoplasms 2Colonic Neoplasms 2Adenocarcinoma Of Esophagus 2Rectal Diseases 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Intestinal Diseases 1Digestive System Diseases 1Colonic Diseases 1Carcinoma, Non-Small-Cell Lung 1Biliary Tract Neoplasms 1

Interventions

Irinotecan 3Bevacizumab 3trimebutine 3-thiocarbamoylbenzenesulfonate 2Leucovorin 2Fluorouracil 2repotrectinib 1pralsetinib 1napabucasin 1encorafenib 1alectinib 1Polyethylene Glycols 1Oxaliplatin 1Ocoxin 1Levoleucovorin 1KRN-330 1Drug Therapy 1Cetuximab 1Capecitabine 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Colonic Diseases × Levoleucovorin × Clear all
NCT04607421 2025-08-14

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Pfizer

Phase 3 Active not recruiting
831 enrolled 2 FDA
Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡